MedtechSourcebook

MLIFE DIAGNOSTICS LLC

Contract manufacturer · Marshall, TX

FDA-registered (openFDA, export of Oct 21, 2026) ISO 13485: not verified

FDA registration
3017060097 (openFDA record; or search FDA's registration database)
FEI number
3017060097
Registered for
FDA registration year 2026
Establishment types
Manufacturer; Contract manufacturer
Owner or operator
mLife Diagnostics LLC (FDA owner/operator no. 10075713)
Registered address
511 N. Washington Ave, Marshall, TX 75670
Contract listings
1 device listings, 11 product codes, first listed Jul 17, 2026
Certification
Not verified. We have no certification data for this facility yet.

Devices listed as contract work

Each row is an FDA product code this facility lists under its contract establishment type, with the date of its earliest such listing.

Product codeDevice (FDA name)ClassCategoryRoleFirst listed
NFTTest, Amphetamine, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NFVTest, Benzodiazepine, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NFWTest, Cannabinoid, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NFYTest, Cocaine And Cocaine Metabolites, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NGGTest, Methamphetamine, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NGLTest, Opiates, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
NGMTest, Phencyclidine (Pcp), Over The CounterUnclassifiedClinical toxicologyContract manufacturingJul 17, 2026
PTGTest, Methadone, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
PTHTest, Barbiturate, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
QAWTest, Tricyclic Antidepressants, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026
QBFTest, Propoxyphene, Over The CounterClass IIClinical toxicologyContract manufacturingJul 17, 2026